Albo addressed the nation on Wednesday night. Eight hours of build-up for three minutes of “enjoy your Easter” and a reminder to catch the bus. The hard questions about what happens if fuel supply gets worse got punted.
The overriding sentiment seemed to be we’ll worry about it after the long weekend. Which is a pretty Aussie way to deal with a crisis.
Trump followed up Thursday claiming the US had “completely won” in Iran, then said they’d need a few more weeks to wrap things up. Gold and silver gave back ground on the contradiction, and the ASX followed.
It was a shortened week, with plenty of noise up top, but the small end kept moving.
Firstly, a Happy Easter from all of us at Equities Club. Now here’s what caught our eye this week:
- 10X builds momentum at Big Badja with its best silver hit yet
- MRD’s chairman puts his money where his mouth is
- Gold and silver soften as the US stays put in Iran
- Uranium juniors surge as sector sentiment returns
- NeuroScientific rockets on Crohn’s disease progress
- We caught up with Cosmo Metals, a $5 million gold explorer with near-term drills
- A humanoid robotics IPO and what it means for the supply chain
Exultant Mining (ASX: 10X) Delivers Record 339 g/t Silver at Big Badja
Exultant Mining (ASX: 10X) dropped more sampling results this week from Big Badja, part of the broader Peak View Project in NSW. And the grades keep climbing.
We had 10X’s exploration manager in studio this week to walk through the results. Video below.
The standout was a new rock chip sample returning 339 g/t silver, 1.8% lead and 0.4 g/t gold. That’s the highest-grade modern assay the company has recorded from the historic workings.
Rock chips are hand-picked samples so they’re not representative of bulk grade, but they tell you the system carries serious metal. And the consistency across multiple samples backs that up – 256 g/t silver, 108 g/t silver, and 93.4 g/t silver with 3.32% lead from earlier rounds.
A trial IP line run across the historic mine confirmed a chargeability anomaly sitting directly beneath the old workings, open at depth. Nobody has ever drilled this target with modern techniques and it’s a first pass at something that could extend the system well beyond what’s visible at surface.
Big Badja sits on a 15 km granite-sediment contact with a 3 km Pb-Zn soil anomaly nearby. There’s a lot of ground still to test across the wider Peak View tenure.
We backed 10X in early February and the team hasn’t slowed down since. At 19c with a $7 million valuation and roughly $4 million in cash, the company is spending money on the ground while the silver price sits in a holding pattern because of Iran. When that resolves, 10X will be well placed to have the targets ready to go.
Mount Ridley Mines (ASX: MRD) Chairman Buys $180k On-Market Ahead of Busy 2026 Catalyst Run
Mount Ridley Mines (ASX: MRD) hosted an investor webinar this week, and the most telling moment had nothing to do with slides.
Chairman David Wall recently bought roughly $180k worth of shares on market. For a junior explorer with a $40 million market cap, that’s a decent cheque. On the webinar, he said he wouldn’t be buying if a near-term capital raise was coming.
That takes one of the main risks off the table heading into a busy stretch.
If you didn’t get the chance to listen in, we have the link here.
We added MRD to the portfolio on March 24 and you can read the full breakdown here. The short version: three critical minerals from one deposit in WA, a maiden JORC resource, a partnership with Lawrence Livermore National Laboratory, and a market cap that looks light next to its nearest peer.
The webinar filled in more colour on the Grass Patch project. The heavy rare earth resource is 41% heavy rare earth elements, with significant dysprosium and terbium endowment – two elements China has slapped export controls on and the same ones the Pentagon is stockpiling.
The peer comparison that keeps coming up is Victory Metals (ASX:VTM), which hosts a similar rare earths system in WA and trades at roughly $207 million.
MRD sits at around $40 million with additional scandium and gallium resources that VTM doesn’t have.
The gap between $40 million and $207 million is where the opportunity sits, and the path from here runs through metallurgy and resource growth.
On the scandium side, MRD already holds the second-largest JORC scandium resource in the western world behind Sunrise Energy (ASX: SRL), which carries a $1.3 billion valuation.
The company has around 20,000 historical drill pulps sitting in storage to be assayed. If those come back with decent grades, the resource grows without a single new hole in the ground.
The 2026 catalyst list is busy:
- Assaying historical pulps for scandium growth potential
- Metallurgical work underway with Lawrence Livermore National Laboratory
- Seven walk up drill targets ready across Grass Patch
- Early flow sheet development
- Downstream partnership and government funding discussions
With $2.5 million in cash and no near-term raise on the horizon, MRD is funded to tick most of that list off through 2026. We’ll be watching closely as they work through it.
Gold Price and Silver Price Retreat as US Stays Put in Iran
Gold had been charging toward US$4,800/oz and silver was up over 10% for the week, nearly touching US$80/oz. The market had priced in the US leaving the Middle East, and precious metals were running on it.
Trump’s Thursday speech killed that momentum. The US looks to be staying put for the next few weeks (at least), and both metals pulled back as traders recalculated.
Right now, gold and silver are trading almost entirely on what happens in Iran. Until there’s a clearer picture on the conflict, we’d expect both to stay choppy.
For small-cap explorers, the soft patch is actually useful. Drill programs take months to plan, permit and execute, and results don’t come back overnight.
Companies doing the work now could have news landing right around the time the conflict picture clears up and sentiment improves. The ones sitting on their hands waiting for a better market will be scrambling to catch up.
We continue to hold our full positions across the precious metals side of the portfolio:
- Black Horse Mining (ASX: BHL) – Drilling for gold in Victoria
- Exultant Mining (ASX: 10X) – On the ground in NSW building towards a near-term gold drilling campaign
- Asian Battery Metals (ASX: AZ9) – Working towards a copper-gold drilling campaign in Mongolia
ASX Uranium Stocks Surge Up to 80% as Sector Sentiment Returns
A few small-cap uranium names had a strong week on the ASX, and we didn’t see it coming.
American Uranium (ASX: AMU) was the standout, up nearly 40% after releasing an updated resource for its Lo Herma Project in Wyoming.
The interim resource now sits at 945 Mlbs eU₃O₈. For a company trading under $20 million, that’s a resource approaching the billion-pound mark.
To put that in context, several producing or near-production ISR operations in Wyoming and Texas are running on resource bases in the tens to low hundreds of millions of pounds.
The deposit also looks suitable for in-situ recovery mining, which is the cheaper end of uranium extraction.
Instead of building an open pit or going underground, ISR circulates solution through the ore body to recover uranium in place. If the project advances, that keeps development costs and complexity well below what a conventional mine would need.
The jump in share price reflects renewed investor appetite for uranium exposure as energy security continues to dominate the macro backdrop.
Cauldron Energy (ASX: CXU) surged almost 80% during the week without any price-sensitive news, which earned it a formal ASX price query. CXU put the move down to broader uranium sector strength and growing attention on nuclear power globally.
Both moves are a reminder of how fast sentiment can swing back into uranium when the macro lines up. These stocks can sit dormant for months and then move 40-80% in a week.
NSB Jumps 40% on Crohn’s Progress
NeuroScientific Biopharmaceuticals (ASX: NSB) was up roughly 40% this week after hitting a manufacturing milestone for its StemSmart™ platform ahead of Phase 2 clinical trials.
StemSmart™ is being developed to treat fistulising Crohn’s disease, one of the most severe forms of Crohn’s where ongoing inflammation creates small tunnels between the bowel and surrounding tissue.
These are extremely difficult to treat and often do not respond to existing therapies, leaving patients with limited options. StemSmart™ is designed to reduce the inflammation driving the disease and support the body’s ability to repair damaged tissue itself.
The company confirmed the first manufacturing transfer run has begun with Q-Gen Cell Therapeutics in Brisbane, which is the step that gets them to actual clinical trial material ahead of a planned Phase 2 study in the second half of 2026.
The global Crohn’s treatment market is expected to exceed US$13 billion, so the commercial prize is huge if the science holds up.
That’s often a big ‘if’ with any biotech, and the share price from here will live and die on trial timing and results, but it’s one for the watch list.
A $5 Million Gold Explorer Worth a Look
We caught up with Cosmo Metals (ASX: CMO) this week. It’s a micro-cap gold and antimony explorer sitting under $5 million with about $1.5 million in cash.
Safe to say it’s firmly in “one good drill hole changes everything” territory.
Managing Director Ian Prentice walked us through what’s coming, and the drill calendar for the next few months is fuller than you’d expect for a company this size.
In WA, CMO is about to drill the Kanowna Gold Project, right next door to Northern Star’s Kanowna Belle operations near Kalgoorlie. An EIS grant is helping fund the program.
The project sits along the same structural corridor that hosts several multi-million ounce deposits, and historical drilling has already returned 18m at 5.3g/t and 10m at 4.7g/t gold. And they’re about to find out if there’s more where that came from.
Over in NSW, CMO controls a big ground position across the historic Bingara goldfields, where recent drilling returned 6m at 9.99g/t gold from just 11m depth.
So it’s shallow, high-grade, and barely scratched.
Two active projects in proven gold regions gives them more than one shot at it, which is as much as you can ask for from a $5 million explorer. It’s worth keeping a close eye on.
Unitree Robotics IPO: What Humanoid Robots Mean for Titanium and the ASX Supply Chain
One of the more interesting IPO stories this week came out of China. Unitree Robotics is preparing to list on the Shanghai Stock Exchange, looking to raise around US$610 million.
Unitree is already profitable. In 2025 the business did roughly US$250 million in revenue and delivered around US$90 million in net profit. Humanoid platforms now make up more than half of core revenue.
That’s worth pausing on. This is a humanoid robotics company that’s actually making money, not burning through cash pitching a prototype.
They’re targeting production capacity of 75,000 humanoid robots annually in the near term. Tesla is aiming to start commercial sales of Optimus by 2027 with ambitions above a million units in the short term.
If even a fraction of those production targets land, the metals demand that follows is enormous. And it could be worth having one or more humanoid associated narrative plays in your shortlist.
We’ve backed Fortuna Metals (ASX: FUN) on this theme. FUN is exploring for rutile in Malawi, right next door to the world’s largest rutile deposit held by Sovereign Metals with Rio Tinto backing.
Every humanoid frame needs titanium, and the cleanest path to titanium is rutile.
At 8.3c with a market cap of roughly $25 million, FUN has a big upside. If the humanoid supply chain story plays out the way the production numbers suggest it could, rutile demand is only heading one direction.
The Week Ahead for ASX Small Caps
Markets will keep swinging on whatever comes out of Iran, or Trump’s press conferences, each day.
Until there’s a clearer picture on the conflict, that’s just how it is. And the fuel supply conversation in Canberra could move from “catch the bus” to something more serious pretty quickly.
Our portfolio is heading into a busy stretch. We’d rather be holding companies doing work during the quiet periods than chasing them after sentiment turns.
Enjoy the long weekend. Eat some chocolate. Try not to look at the price of petrol on the drive home.
Till next week.
General advice warning, disclosure and confidentiality notice
General advice warning
The contents of this document are intended to provide general securities advice only and have been prepared without taking account of your objectives, financial situation or needs. Because of that you should, before taking any action to acquire or deal in, or follow a recommendation (if any) in respect of any of the financial products or information mentioned in this document, consulting your own investment advisor to consider whether that is appropriate having regard to your own objectives, financial situation and needs. If applicable, you should obtain the Product Disclosure Statement relating to the relevant financial product mentioned in this document (which contains full details of the terms and conditions of the relevant financial product) and consider it before making any decision about whether to acquire the financial product. Whilst the Equities Club Pty Ltd (“Equities Club”) believes information contained in this document is based on information which is believed to be reliable, its accuracy and completeness are not guaranteed and no warranty of accuracy or reliability is given or implied and no responsibility for any loss or damage arising in any way for any representation, act or omission is accepted by Equities Club or any officer, agent or employee of Equities Club or any related company.
Neither Equities Club, nor any of its directors, authorised representatives, employees, or agents, makes any representation or warranty as to the reliability, accuracy, or completeness, of this document or any advice. Nor do they accept any liability or responsibility arising in any way (including negligence) for errors in, or omissions from, this document or advice.
Disclosure
The directors, authorised representatives, employees and associated persons of Equities Club may have an interest in the financial products discussed in this document and they may earn brokerage, commissions, fees and advantages, pecuniary or otherwise, in connection with the making of a recommendation or dealing by a client in such financial products. Equities Club owns 1,554,000 FUN shares, 187,500 BHL shares, 1,150,000 AZ9 Shares, 2,083,333 MRD performance rights, and 200,000 10x at the time of publishing this article. Equities Club has been engaged by FUN, BHL, 10X, AZ9 and MRD at the time of writing.
Confidentiality notice
The information contained in and accompanying this communication is strictly confidential and intended solely for the use of the intended recipient/s. The copyright in this communication belongs to Equities Club. If you are not the intended recipient of this communication please delete and destroy all copies immediately.
Equities Club Ltd (CAR No. 001308139) is a corporate authorised representative of ShareX Pty Ltd, Australian Financial Services License (AFSL) No 519872.